Celldex Therapeutics, Inc. Share Price & Technical Analysis
CLDX · $32.60 (+0.28%)
Healthcare / Biotechnology
$32.60
+0.28%
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company's drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate. It develops clinical programs, including Barzol…
Price chart
Seasonality
May has 1 positive and 4 negative years (last 5 years shown)
-7% return in May, -5% avg return in past 3 year May month.
16% return in 2026, -3% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -9% | 22% | 6% | 3% | -7% | – | – | – | – | – | – | – | 16% |
| 25 | -4% | -13% | -15% | 16% | -4% | 3% | 8% | 1% | 18% | 3% | 2% | 2% | 18% |
| 24 | -10% | 36% | -12% | -11% | -11% | 8% | 4% | 8% | -18% | -23% | 6% | -7% | -30% |
| 23 | -2% | -3% | -16% | -12% | 1% | 7% | 5% | -21% | -2% | -15% | 29% | 32% | 3% |
| 22 | -21% | -5% | 15% | -11% | -23% | 15% | 30% | -1% | -6% | 22% | 5% | 21% | 41% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Strong · Uptrend
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company's drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate. It develops clinical programs, including Barzolvolimab (CDX-0159), a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity for treating chronic urticarias, prurigo nodularis, eosinophilic esophagitis, and atopic dermatitis; and CDX-622, a bispecific candidate for inflammatory diseases, which targets two complementary pathways that drive chronic inflammation, potently neutralizing the alarmin thymic stromal lymphopoietin and depleting mast cells through stem cell factor starvation. Celldex Therapeutics, Inc. is headquartered in Hampton, New Jersey.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$2.51B
P/E ratio
—
52W high
$35.79
52W low
$18.55
Volume
1,78,294
Beta
0.98
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Celldex Therapeutics, Inc. share price today?
- Celldex Therapeutics, Inc. (CLDX) last traded around $32.60 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does CLDX have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for CLDX. Download the app for real-time alerts.
- How can I analyze Celldex Therapeutics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.